Att C (amended) _ Pricing Table.xlsx
XLSX spreadsheet 18 KB Posted
- Solicitation number
- 75D301-22-R-72117
About this file
This document contains a solicitation for a repeat, cross-sectional serologic survey to estimate SARS-CoV-2 seroprevalence across the United States. The Centers for Disease Control and Prevention requires testing of residual/remnant/excess, deidentified blood specimens from commercial laboratories nationwide to determine seroprevalence by region, pediatric age groups, and time periods over an 11-month base period and 12-month option period. Offerors will collect monthly commercial lab residual sera samples distributed by age from all 50 states, Washington D.C. and Puerto Rico to be tested for qualitative SARS-CoV-2 nucleocapsid antibodies and quantitative IgG anti-spike antibodies. Offerors will provide CDC with data reports after every 8-week collection/testing period and a final report. Questions are due by January 6, 2022 and proposals are due by January 24, 2022 to the Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services. Pricing terms include unit prices for shipping and assays.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Att B (amended) _ Task Deliverables Table.xlsx | XLSX spreadsheet | |
| Responses to Vendor QA - Att D_Question and Answer Template.xlsx | XLSX spreadsheet | |
| Solicitation Amendment _ Sec. D PWS - RFP 75D301-22-R-72117.docx | DOCX document | |
| RFP 75301-22-R-72117 - MASS-C Serology.doc | DOC document | |
| Att C _ RFP 72117 - Pricing Table.xlsx | XLSX spreadsheet | |
| Att D _ RFP 72117 - Question and Answer Template.xlsx | XLSX spreadsheet | |
| Att A _ RFP 72117 - Offeror Capabilities and Specimens.xlsx | XLSX spreadsheet | |
| Att B _ RFP 72117 - Task Deliverables Table.xlsx | XLSX spreadsheet |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Attachment C
| RFP 75D301-22-R-72117: MULTISTATE ASSESSMENT OF SARS-CoV-2 SEROPREVALENCE | |||||||||||||||
| Base Period: 2/21/2022 - 1/20/2023 | |||||||||||||||
| Offeror Name | Offered Sites | Number of sites | Shipping Unit Price | Shipping Quantity/Unit | Estimated samples per 8 week collection period | Task Area 1 Unit Price Assay A (anti-S quantitative assay) | Task Area 1 Unit Price Assay B (anti-N qualitative assay) | Task Area 1 Assay A Bimonthly Total | Task Area 1 Assay B Bimonthly Total | Task Area 1 Bimonthly Totals | Estimated total contract samples | Task Area 1 Totals | Task Area 2 Unit Price (1 curve) | Task Area 2 Unit Price (2 curve) | Task Area 2 Unit Price (3 curve) |
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Option Period: 12/05/2022 - 12/04/2023 | |||||||||||||||
| Offeror Name | Offered Sites | Number of sites | Shipping Unit Price | Shipping Quantity/Unit | Estimated samples per 8 week collection period | Task Area 1 Unit Price Assay A (anti-S quantitative assay) | Task Area 1 Unit Price Assay B (anti-N qualitative assay) | Task Area 1 Assay A Bimonthly Total | Task Area 1 Assay B Bimonthly Total | Task Area 1 Bimonthly Totals | Estimated total contract samples | Task Area 1 Totals | Task Area 2 Unit Price (1 curve) | Task Area 2 Unit Price (2 curve) | Task Area 2 Unit Price (3 curve) |
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| ADDITIONAL PEDIATRIC SPECIMENS | ||
| Period of | ||
| Performance | Number of Units Proposed | Price |
| Base Period |
(2/21/22 - 1/20/23) Option Period (12/5/22 - 12/4/23)
File details come from the government source that posted it. Updated .